Purpose: Selective laser trabeculoplasty (SLT) is known to reduce intraocular pressure (IOP) effectively. The aim of this study, however, was to evaluate the effect of SLT on ocular haemodynamics. Methods: A total of 69 eyes of 69 patients (age 67.8 AE 9.9 years) with already treated primary open-angle glaucoma who were assigned for SLT for further IOP reduction were consecutively enrolled in this prospective interventional case series. Intraocular pressure, the ocular pulse amplitude (OPA), ocular pulse volume (OPV) and pulsatile ocular blood flow (pOBF) were assessed with the Ocular Blood Flow Analyzer prior to and 3 months after SLT. Results: Intraocular pressure was statistically significantly reduced from 16.0 AE 5.4 mmHg to 12.8 AE 4.0 mmHg (p = 0.001). The OPA did not change (p = 0.783) after IOP reduction following SLT. OPV and pOBF increased statistically significantly. OPV increased from 7.33 AE 3.05 to 8.59 AE 3.35 ll (17.2%; p = 0.001) and pOBF from 17.11 AE 5.42 to 19.74 AE 6.59 ll/s (15.4%; p = 0.002). Conclusion: Selective laser trabeculoplasty probably does not induce any pharmacological changes effecting systemic blood pressure or ocular blood flow as topical IOP-lowering medication might do, nor does it change biomechanical properties of the eye as surgery could. Therefore, an increase in ocular blood flow following SLT can only be explained by the reduction in IOP and might be a sign of dysfunctional autoregulation in glaucoma patients.
Introduction
Intraocular pressure (IOP) is still the most important modifiable risk factor (Collaborative 1998; Heijl et al. 2002; Kass et al. 2002) for the development and progression of POAG. Impaired vascular circulation of the optic nerve head is another relevant risk factor, which also influences the development and progression of POAG (Phelps & Corbett 1985; Hayreh 1997; Anderson 1999; Drance 2001; Huck et al. 2014) . Selective laser trabeculoplasty (SLT) is known to lower IOP effectively in treatment naive as well as in already treated glaucoma patients (McIlraith et al. 2006; Ayala 2014) . Moreover, sideeffects of SLT are rare.
The aim of this study, however, was to evaluate the effect of SLT on ocular haemodynamics. Ocular pulse amplitude and pulsatile blood flow, a measure of choroid blood flow, were measured with the Ocular Blood Flow Analyzer (OBF; Paradigm Medical Industries, Inc., San Diego, CA, USA), which offers a simple non-invasive method to quantify ocular perfusion in a clinical setting. As SLT presumably does not change ocular biomechanics and as there is no direct effect on the ocular and/or systemic vascular system, this study assesses the effect of IOP reduction on pulsatile blood flow, an important component of ocular blood flow.
Patients and Methods
In a prospective interventional case series 69 eyes (31 right eyes, 38 left eyes) of 69 patients (age 67.8 AE 9.9 years; 22 males; 47 females) with already treated primary open-angle glaucoma (POAG) who were assigned for SLT for further IOP reduction, that is to reach target pressure, were consecutively enrolled. They were recruited from glaucoma patients, admitted for a one-day routine glaucoma work-up in a tertiary university hospital glaucoma service. In the case of two eligible eyes, one was randomly selected. High-pressure glaucoma (HPG; n = 60) was defined as primary open-angle glaucoma with a history of untreated IOP higher than 21 mmHg, typical nerve fibre layer defects, corresponding glaucomatous optic nerve head damage or typical visual field defects and no other ocular or systemic diseases that might cause visual field defects. Normal-pressure glaucoma (NPG; n = 9) with a history of untreated IOP equal or less than 21 mmHg, otherwise the same criteria applied as for HPG.
Patients who had already undergone ophthalmic surgery (other than uncomplicated phacoemulsification at least 3 months prior to study entry) and patients under 18 years of age were excluded.
Selective laser trabeculoplasty (SLT) was performed with the Ellex SLT laser (SoloTM, ellex Inc., Adelaide, Australia) using a Latina SLT goniolens (Ocular Instr., Bellevue, USA) to visualize the trabecular meshwork. The initial energy level was set to 0.8 mJ and adapted according to the degree of angle pigmentation and bubble formation. In a generally accepted treatment mode, 100 nonoverlapping spots were applied to 360°of the trabecular meshwork in a single session. No antiinflammatory medication was applied postoperatively, and the number of glaucoma medications and substances was not changed or discontinued in the treated as well as the fellow eye. During follow-up, participants had no additional surgery or intervention nor a change in systemic medication.
Intraocular pressure (IOP) and the ocular pulse amplitude (OPA) were measured in a sitting position prior to and 3 months after SLT with the Ocular Blood Flow Analyzer (OBF; Paradigm Medical Industries, Inc., San Diego, CA, USA). This is a highly sensitive pneumotonometer, utilizing continuous air flow pneumotonometry to record IOP on five consecutive cardiac cycles, enabling non-invasive, reproducible (Butt & O'Brien 1995) and accurate (Silver & Farrell 1994) measurements of the OPA (mmHg) over time with minimal disturbance of the eye. The OPA represents the difference between the systolic and diastolic IOP (Langham & To'Mey 1978) . Together with the analysis of the IOP pulse waveform and the pulse rate (PR), OPA provides the basis for calculating the pulsatile ocular blood flow (pOBF) Silver et al. 1989; Silver & Farrell 1994) . The OBF device records five consecutive ocular pulses and calculates IOP, OPA, ocular pulse volume (OPV), pulse rate and pOBF means.
Blood pressure (BP) was recorded shortly before OBF measurements at the brachial artery using a blood pressure cuff and stethoscope according to Riva-Rocci.
After approval of the protocol by the Institutional Review Board of the Medical Faculty of the Technische Universit€ at Dresden, Germany, an informed consent was obtained from each participant. All procedures were in accordance with the Declaration of Helsinki.
Statistical analysis
All measurements are given as mean AE standard deviation. Correlation was calculated by Pearson's correlation coefficient. The two-tailed paired Student's t-test was used to compare the data before and after SLT. The influencing factors on a parameter were determined by a multivariate linear regression analysis with stepwise inclusion. SPSS 21 (IBM Corp., Armonk, NY, USA) served as the statistical software.
Results
Following SLT, IOP was reduced statistically significantly from 16.0 AE 5.4 mmHg to 12.8 AE 4.0 mmHg (p = 0.001) at 3 months. The pulse volume increased statistically significantly from 7.33 AE 3.05 to 8.59 AE 3.35 ll (17.2%; p = 0.001) and pOBF from 17.11 AE 5.42 to 19.74 AE 6.59 ll/s (15.4%; p = 0.002). All other parameters like pulse amplitude, pulse rate, systemic systolic and diastolic blood pressure as well as pulse pressure did not change statistically significantly (Table 1) .
A strong correlation exists between IOP reduction and the increase in pOBF (r = À0.682; p = 0.001) (Fig. 1) . In a multivariate regression analysis, change in IOP is only correlated with the preoperative IOP (r²=0.486, p = 0.001).There was no correlation found between a change in IOP and age (r = 0.058, p = 0.639), gender (r = 0.072, p = 0.414) and type of glaucoma (r = À0.159, p = 0.069). An alteration in pOBF was merely dependent on the change in IOP (r²=0.387, p = 0.001). A dependency was not established between a change in pOBF and age, gender, type of glaucoma, blood pressure parameters or the type of IOP-lowering medication (Table 2) . IOP = Goldmann correlated intraocular pressure, OPA = ocular pulse amplitude, OPV = ocular pulse volume, pOBF = pulsatile ocular blood flow, BPsys = systolic blood pressure, BPdiast = diastolic blood pressure, PP = pulse pressure.
Discussion
In the present study, we evaluated the effect of IOP reduction following SLT on ocular haemodynamics as measured with the Ocular Blood Flow Analyzer (OBF; Paradigm Medical Industries, Inc., San Diego, CA, USA). Until now, SLT is assumed not to have any pharmacological effects on systemic BP and/or ocular blood flow. Changes in haemodynamic parameters as measured with the OBF system might be due to changes in ocular biomechanics. In a recent study, however, we clearly demonstrated that SLT has no effect on corneal biomechanics (Pillunat et al. 2016) , which are speculated to reflect a possible relationship to biomechanical characteristics of posterior ocular tissues such as the peripapillary sclera and the lamina cribrosa. Therefore, it seems very likely that the changes in OPV and pOBF following SLT actually reflect an increase in total ocular blood flow after IOP reduction. Although the calculation of pOBF from OPA measurements is controversial, this is of lesser importance when intra-individual changes are of interest. Langham Langham et al. 1989 ) and Silver Silver & Farrell 1994) demonstrated well, that under certain circumstances, the change in IOP measurements within the cardiac cycle over time can be used to calculate the flow. The pulsatile component of ocular blood flow can be obtained from these measurements of the pulse amplitude over time. The steady component of ocular blood flow cannot be determined with this measuring technique. Onda et al. (1995) have shown that the peripapillary choroid contributes to some extent to the arterial vascular supply of the anterior optic nerve. They showed that branches of the short posterior ciliary arteries do not only supply the anterior optic nerve but also the adjacent peripapillary choroid as well as the more peripheral choroid. Although the vascular contribution of the peripapillary choroid to the anterior optic nerve is minor, the fact that choroidal blood flow is the major component (>90%) of total blood flow (Alm 1992 ) and the pulsatile flow represents 75% to 85% of total flow Langham et al. 1989) , choroidal flow may somehow reflect the vascular situation at the optic nerve head.
Ocular pulse amplitude (OPA) was not influenced by IOP change following SLT in this group of glaucoma patients. Previous studies have shown that there is a positive correlation between IOP and OPA in healthy subjects (Kaufmann et al. 2006; Knecht et al. 2011) . This is necessary to maintain a relatively constant level of blood flow when IOP changes and is a sign of functioning autoregulation. Most glaucoma medications have no effect on OPA despite IOP reduction (Mittag et al. 1994; Schmidt et al. 1998 ). Therefore, there must be factors other than IOP influencing OPA in glaucoma patients. Possibly an OPA, which is not affected by IOP change, is a sign of insufficient autoregulation in glaucoma patients.
Ocular pulse amplitude (OPA), the difference between the mean systolic and diastolic IOP, mainly depends on ocular rigidity (Perkins 1981; Ravalico et al. 1996) , systemic blood pressure and pulse rate (Ravalico et al. 1996) . As these remain unchanged by SLT, this could be another explanation why OPA was not affected by IOP reduction in this study of glaucoma patients.
Intraocular pressure (IOP) reduction following SLT caused a significant rise in OPV. Friedland (1983) showed in his equation that there is a relation between OPA, IOP and OPV. In healthy subjects, the OPA correlates positively with IOP, which implies a nearly constant OPV due to sufficient autoregulation. In glaucoma patients however, the OPA does not change after IOP reduction. This can only be explained by an increase of the OPV and could be another sign of insufficient autoregulation.
There was a significant increase in pOBF after IOP lowering following SLT, which represents the volume flow per second. As SLT has no pharmacological influence on ocular or systemic haemodynamics like IOPlowering topical medication might have and presumably ocular biomechanical parameters are not changed, this effect can only be attributed to the change in IOP. As Krakau (1992) has, pOBF does not depend on the amplitude of the pulse wave but rather on the pulse volume wave. In healthy subjects, retinal and optic nerve head blood flow does not change despite the changes in IOP. This autoregulatory capacity keeps ocular perfusion pressures stable in different vascular beds (Pillunat et al. 1997; Fuchsjager-Mayrl et al. 2004 ). In patients suffering from open-angle glaucoma, the range of the autoregulatory capacity seems to be reduced or completely absent (Pillunat et al. 1985 (Pillunat et al. , 1987 Fuchsjager-Mayrl et al. 2004) . As a consequence, the optic nerve head of glaucoma patients seems to be more vulnerable for IOP changes as these automatically lead to changes in ocular perfusion pressures. Quaranta et al. (1994) have shown a decrease in pOBF when increasing IOP with a suction cup in NPG patients, postulating a lack of myogenic autoregulation. They did not refer to OPA and OPV. If the blood flow changes in response to IOP changes, we can probably consider impaired autoregulation (Pillunat et al. 1985 (Pillunat et al. , 1987 Fuchsjager-Mayrl et al. 2004 ).
The present study demonstrates that SLT increases OPV and pulsatile ocular blood flow without altering the OPA. Maybe an OPA, which is not affected by IOP change and a pOBF that is affected by IOP change, represents a sign of insufficient autoregulation in glaucoma patients. As topical and systemic treatment was not changed during follow-up, and SLT presumably has no effect on ocular biomechanics or on ocular and systemic circulation, these haemodynamic changes can be solely attributed to the IOP reducing therapeutic intervention. It proves that IOP reduction can enhance blood flow in glaucoma patients. 
